// App-Quantinova.ai

O39 : VTE risk in the general population: applying context to the impact of JAK inhibition

Researchers

Presenter

  • Serena Baroncini

Principal Investigators

  • Mark Yates

  • Katie Bechman

  • Sanjeev Patel

  • Andrew Rutherford

  • Alexander Kleymann

  • James Galloway

Medical Centers

  • King's College Hospital, Rheumatology, London, UNITED KINGDOM

  • King's College Hospital, Rheumatology, London, UNITED KINGDOM

  • University Hospital Dresden Carl Gustav Carus, 3rd Medical department, Dresden, GERMANY

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved